Agilent Technologies, Inc. $A Position Boosted by Lmcg Investments LLC

Lmcg Investments LLC boosted its holdings in Agilent Technologies, Inc. (NYSE:A) by 7.7% during the 1st quarter, Holdings Channel reports. The fund owned 93,891 shares of the medical research company’s stock after acquiring an additional 6,697 shares during the quarter. Lmcg Investments LLC’s holdings in Agilent Technologies were worth $10,702,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Whittier Trust Co. boosted its position in Agilent Technologies by 3.1% during the 1st quarter. Whittier Trust Co. now owns 4,570 shares of the medical research company’s stock worth $525,000 after acquiring an additional 137 shares during the period. Stephens Inc. AR grew its stake in shares of Agilent Technologies by 21.0% in the first quarter. Stephens Inc. AR now owns 5,960 shares of the medical research company’s stock worth $679,000 after purchasing an additional 1,036 shares in the last quarter. Howe & Rusling Inc. acquired a new position in shares of Agilent Technologies during the first quarter valued at $243,000. V Square Quantitative Management LLC increased its holdings in shares of Agilent Technologies by 4.6% during the first quarter. V Square Quantitative Management LLC now owns 7,091 shares of the medical research company’s stock valued at $808,000 after purchasing an additional 312 shares during the period. Finally, HB Wealth Management LLC raised its stake in shares of Agilent Technologies by 26.6% during the first quarter. HB Wealth Management LLC now owns 15,004 shares of the medical research company’s stock valued at $1,710,000 after purchasing an additional 3,151 shares in the last quarter.

Agilent Technologies Trading Down 1.8%

Agilent Technologies stock opened at $128.77 on Thursday. The firm’s 50 day moving average price is $124.91 and its two-hundred day moving average price is $125.73. The firm has a market cap of $36.37 billion, a price-to-earnings ratio of 25.86, a price-to-earnings-growth ratio of 2.33 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s payout ratio is 20.48%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on A. Wells Fargo & Company reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. HSBC decreased their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Finally, Sanford C. Bernstein started coverage on shares of Agilent Technologies in a research note on Friday, June 26th. They set an “outperform” rating and a $155.00 price objective on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $160.88.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.